Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ultrastructural Pathology|July 11, 2006
Pitfalls and caveats in BRCA sequencingBeatriz Bellosillo, Ignacio Tusquets
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2020
Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?José Alberto Domínguez-Alonso, David Conde-Estévez, David Bosch, et al.
Cancer Genetics and Cytogenetics|March 11, 2006
The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinomaCristina Corzo, Josep M Corominas, Ignacio Tusquets, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 25, 2007
Does polysomy of chromosome 17 have a role in ERBB2 and topoisomerase IIalpha expression? Gene, mRNA and protein expression: a comprehensive analysisCristina Corzo, Beatriz Bellosillo, Josep M Corominas, et al.
Medicina Clinica|January 22, 2004
[Epidemiological study of the GEICAM group about breast cancer in Spain (1990-1993): El Alamo project]Miguel Martín, Antonio Llombart-Cussac, Ana Lluch, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 3, 2005
Characterization of HER1 (c-erbB1) status in locally advanced breast cancer using fluorescence in situ hybridization and immunohistochemistryCristina Corzo, Ignacio Tusquets, Marta Salido, et al.
Anti-Cancer Drugs|November 25, 2011
Multicenter, phase II, nonrandomized study of docetaxel plus trastuzumab every 21 days as the primary therapy in metastatic breast cancer overexpressing HER2Sonia Servitja, Manuel Ramos, Miguel Gil, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the treatment of early breast cancerSonia del Barco Berrón, Eva Ciruelos Gil, Ignacio Tusquets Trías de Bes, et al.
Breast (Edinburgh, Scotland)|November 29, 2007
Time-to-progression in breast cancer: a stratification model for clinical trialsJuan de la Haba-Rodríguez, Enrique Aranda, Antonio Llombart, et al.
Frontiers in Oncology|February 28, 2022
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerAlberto Ocaña, Jose Ignacio Chacón, Lourdes Calvo, et al.
Pageof 2